Use of follicle-stimulating hormone alone (urofollitropin*) to stimulate the ovaries for assisted conception after pituitary desensitization

This publication has 20 references indexed in Scilit:

• Assisted reproductive technology in the United States and Canada: 1991 results from the Society for Assisted Reproductive Technology generated from The American Fertility Society Registry
  Fertility and Sterility, 1993
• REVIEW: Effects of gonadotrophin-releasing hormone agonists (GnRHa) on follicle and oocyte quality
  Human Reproduction, 1993
• French national IVF registry: analysis of 1986 to 1990 data
  Fertility and Sterility, 1993
• The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials
  Fertility and Sterility, 1992
• Expectations of assisted conception for infertility.
  BMJ, 1992
• Randomized trial of three luteinizing hormone-releasing hormone analogues used for ovarian stimulation in an in vitro fertilization program
  Fertility and Sterility, 1992
• A prospective controlled study of in-vitro fertilization, gamete intra-Fallopian transfer and intrauterine insemination combined with superovulation
  Human Reproduction, 1992
• Equivalency of human menopausal gonadotropin and follicle-stimulating hormone stimulation after gonadotropin-releasing hormone agonist suppression
  Fertility and Sterility, 1990
• Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization
  Fertility and Sterility, 1987
• ENDOMETRIOSIS AND OVULATORY DISORDER: REDUCED FERTILISATION IN VITRO COMPARED WITH TUBAL AND UNEXPLAINED INFERTILITY
  The Lancet, 1985